Trial intelligence / Profile preview

Effect of propofol versus desflurane and sevoflurane on rocuronium onset and recovery

ChiCTR1900027234Phase 4Not yet recruiting

Sponsor
Beijing Chaoyang Hospital, Capital Medical University
Start
Nov 2019
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of rocuronium, propofol, desflurane and sevoflurane (3 arms), sponsored by Beijing Chaoyang Hospital, Capital Medical University. Primary endpoints: Clinical effect time, Onset time of muscle relaxation and 1 more. Planned start Nov 2019; status: not yet recruiting.

02

Drugs

rocuroniumpropofoldesfluranesevoflurane

Beyond the preview

Go deeper on ChiCTR1900027234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call